Tardy C - Search Results

1

Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling.

Keller L, Tardy C, Ligat L, Le Pennec S, Bery N, Koraïchi F, Chinestra P, David M, Gence R, Favre G, Cabantous S, Olichon A. Keller L, et al. Among authors: tardy c. Front Immunol. 2022 Aug 18;13:980539. doi: 10.3389/fimmu.2022.980539. eCollection 2022. Front Immunol. 2022. PMID: 36059552 Free PMC article.

2

Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer.

Keller L, Tardy C, Ligat L, Gilhodes J, Filleron T, Bery N, Rochaix P, Aquilina A, Bdioui S, Roux T, Trinquet E, Favre G, Olichon A. Keller L, et al. Among authors: tardy c. Anal Chem. 2021 Apr 20;93(15):6104-6111. doi: 10.1021/acs.analchem.0c05137. Epub 2021 Apr 7. Anal Chem. 2021. PMID: 33825439

3

Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities.

Keller L, Bery N, Tardy C, Ligat L, Favre G, Rabbitts TH, Olichon A. Keller L, et al. Among authors: tardy c. Antibodies (Basel). 2019 Jan 9;8(1):8. doi: 10.3390/antib8010008. Antibodies (Basel). 2019. PMID: 31544814 Free PMC article.

4

A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency.

Lagresle-Peyrou C, Olichon A, Sadek H, Roche P, Tardy C, Da Silva C, Garrigue A, Fischer A, Moshous D, Collette Y, Picard C, Casanova JL, André I, Cavazzana M. Lagresle-Peyrou C, et al. Among authors: tardy c. Haematologica. 2021 Feb 1;106(2):404-411. doi: 10.3324/haematol.2019.230250. Haematologica. 2021. PMID: 31919089 Free PMC article.

5

Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle).

Tardy C, Codogno P, Autefage H, Levade T, Andrieu-Abadie N. Tardy C, et al. Biochim Biophys Acta. 2006 Apr;1765(2):101-25. doi: 10.1016/j.bbcan.2005.11.003. Epub 2005 Dec 27. Biochim Biophys Acta. 2006. PMID: 16412578 Review.

6

[Sphingolipid-mediated apoptotic signaling pathways].

Cuvillier O, Andrieu-Abadie N, Ségui B, Malagarie-Cazenave S, Tardy C, Bonhoure E, Levade T. Cuvillier O, et al. Among authors: tardy c. J Soc Biol. 2003;197(3):217-21. J Soc Biol. 2003. PMID: 14708343 Review. French.

7

Ceramide in apoptosis: a revisited role.

Levade T, Malagarie-Cazenave S, Gouazé V, Ségui B, Tardy C, Betito S, Andrieu-Abadie N, Cuvillier O. Levade T, et al. Among authors: tardy c. Neurochem Res. 2002 Aug;27(7-8):601-7. doi: 10.1023/a:1020215815013. Neurochem Res. 2002. PMID: 12374195 Review.

8

Sphingolipid signalling: molecular basis and role in TNF-alpha-induced cell death.

Malagarie-Cazenave S, Andrieu-Abadie N, Ségui B, Gouazé V, Tardy C, Cuvillier O, Levade T. Malagarie-Cazenave S, et al. Among authors: tardy c. Expert Rev Mol Med. 2002 Dec 20;4(28):1-15. doi: 10.1017/S146239940200546X. Expert Rev Mol Med. 2002. PMID: 14987386 Review.

9

Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D.

Tardy C, Tyynelä J, Hasilik A, Levade T, Andrieu-Abadie N. Tardy C, et al. Cell Death Differ. 2003 Sep;10(9):1090-100. doi: 10.1038/sj.cdd.4401272. Cell Death Differ. 2003. PMID: 12934083

10

Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism?

Tardy C, Andrieu-Abadie N, Salvayre R, Levade T. Tardy C, et al. Neurochem Res. 2004 May;29(5):871-80. doi: 10.1023/b:nere.0000021232.05175.38. Neurochem Res. 2004. PMID: 15139286 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page